News tagged ‘BreastCancer’ clear
- A study led by Dr. Richard Gelber found that treating HER-2 positive breast cancer for one year with trastuzumab remains the standard of care. Researchers compared outcomes of the standard one-year course to a two-year treatment and a six-month treatment, and determined the one-year course was most beneficial.
- Dana-Farber patient Tara Shuman of Canton, who was diagnosed with breast cancer in August 2012, chronicles her journey and shares how she gained perspective and awareness during her battle with the disease.
- Children diagnosed with cancer remain at risk from a variety of serious, long-term complications. Dr. Lisa Diller from Dana-Farber/Children's Hospital Cancer Center says that new treatments can mitigate these risks for the next generation of pediatric cancer survivors.
Tags: BreastCancer, ChildhoodCancer, Survivorship
- Dana-Farber researchers, including Dr. Kornelia Polyak, have developed a mathematical model to predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.
Tags: BreastCancer, Genomics
- Research by Shoshana Rosenberg, ScD, shows that most breast cancer patients under 40 choose to have a mastectomy, even though a less radical lumpectomy procedure, combined with radiation, has the same overall survival.
- Dr. Ann Partridge comments on a new study that shows women ages 40 to 59, who had yearly mammograms, received no added survival benefit up to 25 years later compared with those who skipped the screening.
- Researchers including scientists from Dana-Farber found an association between regularly eating peanut butter and having a lower risk of developing breast disease in early adulthood.
Tags: BasicResearch, BreastCancer
- A new study suggests that women should be taking the breast cancer drug tamoxifen for twice as long as is now customary. Dr. Eric P. Winer said that even women who completed their five years of tamoxifen months or years ago might consider starting on the drug again. Dr. Judy Garber added that while many women don't feel well while taking hormone therapies like tamoxifen, they consider it their safety net.
Tags: BreastCancer, Hormones, Prevention
Showing 11-20 of 52 items